The Clinical Impact of SARS-CoV-2 on Hypertrophic Cardiomyopathy.

Danish SalehZhiying MengNicholas JohnsonAbigail BaldridgeAllison R ZielinskiLubna Choudhury

Published in: Journal of cardiovascular development and disease (2024)

In patients with HCM, COVID-19 infection is associated with increased incidence of myocardial injury, increased number of total and heart-failure specific hospitalizations, and increased mortality.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
sars cov
heart failure
risk factors
cardiac resynchronization therapy
cardiovascular events
respiratory syndrome coronavirus
type diabetes